MX2023005451A - Capsulas de gel blando de liberacion retardada. - Google Patents

Capsulas de gel blando de liberacion retardada.

Info

Publication number
MX2023005451A
MX2023005451A MX2023005451A MX2023005451A MX2023005451A MX 2023005451 A MX2023005451 A MX 2023005451A MX 2023005451 A MX2023005451 A MX 2023005451A MX 2023005451 A MX2023005451 A MX 2023005451A MX 2023005451 A MX2023005451 A MX 2023005451A
Authority
MX
Mexico
Prior art keywords
delayed release
soft gel
gel capsules
shell composition
release soft
Prior art date
Application number
MX2023005451A
Other languages
English (en)
Spanish (es)
Inventor
Karunakar Sukuru
Qi Fang
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of MX2023005451A publication Critical patent/MX2023005451A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
MX2023005451A 2020-11-11 2021-11-10 Capsulas de gel blando de liberacion retardada. MX2023005451A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063112453P 2020-11-11 2020-11-11
PCT/US2021/072326 WO2022104339A1 (en) 2020-11-11 2021-11-10 Delayed release softgel capsules

Publications (1)

Publication Number Publication Date
MX2023005451A true MX2023005451A (es) 2023-05-23

Family

ID=81601948

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023005451A MX2023005451A (es) 2020-11-11 2021-11-10 Capsulas de gel blando de liberacion retardada.

Country Status (13)

Country Link
US (1) US20230404926A1 (cg-RX-API-DMAC7.html)
EP (1) EP4243772A4 (cg-RX-API-DMAC7.html)
JP (2) JP7830457B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230106642A (cg-RX-API-DMAC7.html)
CN (1) CN116648238A (cg-RX-API-DMAC7.html)
AR (1) AR124043A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021379780A1 (cg-RX-API-DMAC7.html)
CA (1) CA3197522A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023007162A2 (cg-RX-API-DMAC7.html)
IL (1) IL302753A (cg-RX-API-DMAC7.html)
MX (1) MX2023005451A (cg-RX-API-DMAC7.html)
TW (1) TW202233164A (cg-RX-API-DMAC7.html)
WO (1) WO2022104339A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024035910A1 (en) * 2022-08-12 2024-02-15 R.P. Scherer Technologies, Llc Coated enteric softgel capsules
BE1030925B1 (nl) * 2022-09-29 2024-04-29 Oystershell Nv Zachte gummy
US12440517B2 (en) 2022-09-29 2025-10-14 Oystershell Nv Soft gummy
US20260124163A1 (en) * 2022-09-29 2026-05-07 Oystershell Nv Soft gummy
BE1030928B1 (nl) * 2022-09-29 2024-04-29 Oystershell Nv Zachte gummy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944096B2 (ja) * 1979-12-24 1984-10-26 森下仁丹株式会社 親水性物質を充填物とするゼラチンカプセルの製造方法
DE60238269D1 (de) * 2001-11-22 2010-12-23 Morishita Jintan Co Nicht-gelatinöse Kapseln
AU2013200828A1 (en) * 2002-12-18 2013-03-07 Pain Therapeutics Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
US20120301546A1 (en) * 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
GB201304662D0 (en) * 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
WO2015200149A1 (en) * 2014-06-23 2015-12-30 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
CA2960620C (en) * 2014-10-06 2018-06-19 Fuji Capsule Co., Ltd. Method of manufacturing enteric seamless soft capsule
MY184967A (en) * 2014-10-06 2021-04-30 Fuji Capsule Co Ltd Method of producing enteric soft capsule
WO2017019808A1 (en) * 2015-07-27 2017-02-02 Catacore, Inc Compositions for the treatment of cataracts
SG11201901177VA (en) * 2016-08-17 2019-03-28 Eupraxia Pharmaceuticals Inc Sustained local delivery of drugs including antibiotics
CN114072138A (zh) * 2019-06-03 2022-02-18 R.P.谢勒技术有限公司 延迟释放软凝胶胶囊
EP4674410A3 (en) * 2019-10-28 2026-03-18 R.P. Scherer Technologies, LLC Delayed release softgel capsules in higher ph environment

Also Published As

Publication number Publication date
EP4243772A1 (en) 2023-09-20
AR124043A1 (es) 2023-02-08
JP2023548711A (ja) 2023-11-20
AU2021379780A1 (en) 2023-07-06
TW202233164A (zh) 2022-09-01
WO2022104339A1 (en) 2022-05-19
CO2023007162A2 (es) 2023-06-20
KR20230106642A (ko) 2023-07-13
IL302753A (en) 2023-07-01
US20230404926A1 (en) 2023-12-21
EP4243772A4 (en) 2024-10-23
CA3197522A1 (en) 2022-05-19
JP7830457B2 (ja) 2026-03-16
JP2026086902A (ja) 2026-05-26
CN116648238A (zh) 2023-08-25

Similar Documents

Publication Publication Date Title
MX2023005450A (es) Capsulas de gel blando de liberacion retardada.
CO2023007162A2 (es) Cápsulas de gelatina blanda de liberación retardada
MX2021014922A (es) Capsulas de gel blando de liberacion retardada.
PE20252788A1 (es) Composiciones de biomasa que contienen pectina activada, productos y metodos de produccion
MX2022005050A (es) Cápsulas de gelatina blanda de liberación retardada en entorno de ph más alto.
AR115269A1 (es) Cápsulas de gelatina blanda entéricas
CO2022019321A2 (es) Cápsulas de gel de liberación retardada
AR104458A1 (es) Cartucho biodegradable para escopetas
CL2024001266A1 (es) Compuestos de tienopirrol.
BR112022005755A2 (pt) Formulações de cápsula de gel macio não animal, métodos de preparação, e métodos de uso das mesmas
MX2024000409A (es) Capsula de gelatina blanda.
MX2015002976A (es) Composicion farmaceutica.
FI3694962T3 (fi) Prosessoitu öljy käsittäen monoasyyliglyseridejä
BR112021006627A2 (pt) composição líquida encapsulada
AR123805A1 (es) Cápsulas blandas de liberación modificada
CL2023001298A1 (es) Tecnología de encapsulación de cannabinoides
AR062374A1 (es) Metodo para prevenir la cristalizacion
MX2025010902A (es) Estabilidad mejorada de ingredientes farmaceuticos activos (api) en capsulas blandas
MX2020005796A (es) Composiciones que comprenden microcapsulas sensibles al ph.
CO2021016625A2 (es) Cápsula de tipo desintegración retardada y método para producir la misma
AR087032A1 (es) Composiciones de capsulas de gelatina y metodos para fabricarlas
PE20211200A1 (es) Proceso de encapsulacion de ciclohexanodionas y producto
MX2023003229A (es) Composicion para mejorar la absorcion de suplementos.
GEAP202516741A (en) Palatable orodispersible formulation of vortioxetine
UY40206A (es) Una composición agroquímica